LordsMed, the global healthcare division of Mumbai-based Lord’s Mark Industries, has launched a set of 10 world-class reagent and diagnostic testing kits for Triglycerides, Uric Acid, Alkaline Phosphatase, Bilirubin, Calcium (Arsenazo III), Creatinine, Glucose, Serum Glutamic Oxaloacetic Transaminase (SGOT)/Aspartate Aminotransferas, Serum Glutamic Pyruvic Transaminase (SGPT), Alanine Aminotransferase (ALT) and Total Protein.

These reagent and diagnostic test kits come with 99.7 percent accuracy, the highest level of sensitivity, a shelf-life of 24 months, unique packaging and competitive price-points. The company has filed India patents for these kits which will strengthen the preventive healthcare mechanism for critical diseases.

LordsMed will manufacture these reagent and diagnostic testing kits at its manufacturing facility in Maharashtra and make these kits available to pathological labs, hospitals and research institutes through its Pan-India distribution network of over 300 dealers. 

The company will use the kits in its chain of pathological labs as well. There are plans to export the reagent and kits in key global markets. LordsMed aims to generate revenue worth Rs 200 crore by supplying these kits Pan India and within SAARC, African and Eastern Europe countries in global markets within couple of years.

LordsMed has its manufacturing facility at Vasai and the company is currently in the final stage of establishing its second and third manufacturing facilities in Lucknow, Uttar Pradesh, and Silvassa, Union Territory of Dadra & Nagar Haveli respectively.